Bessemer Group Inc Supernus Pharmaceuticals, Inc. Transaction History

Bessemer Group Inc

$60.7 Billion
Q3 2024

A detailed history of Bessemer Group Inc transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Bessemer Group Inc holds 262 shares of SUPN stock, worth $10,100. This represents 0.0% of its overall portfolio holdings.

Number of Shares

262

Previous 322 18.63%

Holding current value

$10,100

Previous $8,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$25.77 - $35.16 $1,546 - $2,109	-60 Reduced 18.63%	262 $8,000
Q2 2024 Aug 13, 2024	BUY	$25.99 - $33.85 $6,003 - $7,819	231 Added 253.85%	322 $8,000
Q1 2024 May 13, 2024	SELL	$27.11 - $35.17 $3,497 - $4,536	-129 Reduced 58.64%	91 $3,000
Q4 2023 Feb 09, 2024	BUY	$22.72 - $29.68 $1,136 - $1,484	50 Added 29.41%	220 $7,000
Q3 2023 Nov 13, 2023	BUY	$27.57 - $32.91 $468 - $559	17 Added 11.11%	170 $5,000
Q2 2023 Aug 10, 2023	BUY	$29.91 - $38.73 $1,345 - $1,742	45 Added 41.67%	153 $4,000
Q1 2023 May 10, 2023	SELL	$34.93 - $42.03 $908 - $1,092	-26 Reduced 19.4%	108 $4,000
Q1 2022 May 12, 2022	SELL	$28.51 - $32.9 $712 - $822	-25 Reduced 15.72%	134 $4,000
Q4 2021 Jan 27, 2022	SELL	$26.37 - $34.22 $3,428 - $4,448	-130 Reduced 44.98%	159 $5,000
Q4 2020 Feb 09, 2021	BUY	$17.7 - $25.81 $5,115 - $7,459	289 New	289 $7,000
Q4 2019 Feb 04, 2020	SELL	$19.93 - $29.13 $5,480 - $8,010	-275 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$25.47 - $33.37 $7,004 - $9,176	275 New	275 $8,000
Q2 2019 Jul 19, 2019	BUY	$29.96 - $38.87 $0 - $0	0 New	0 $0
Q1 2019 May 13, 2019	SELL	$32.77 - $41.99 $180,235 - $230,945	-5,500 Closed	0 $0
Q3 2018 Nov 06, 2018	SELL	$42.7 - $56.55 $38,430 - $50,895	-900 Reduced 14.06%	5,500 $277,000
Q2 2018 Jul 25, 2018	BUY	$44.1 - $59.85 $282,240 - $383,040	6,400 New	6,400 $383,000

Others Institutions Holding SUPN

# of Institutions

283

Shares Held

60.6M

Call Options Held

27.7K

Put Options Held

11.3K

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $2.06B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.

Account

Bessemer Group Inc Supernus Pharmaceuticals, Inc. Transaction History